These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1934859)

  • 1. Detection of prenatal drug exposure in the pregnant women and her newborn infant.
    Ostrea EM; Welch RA
    Clin Perinatol; 1991 Sep; 18(3):629-45. PubMed ID: 1934859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance abuse in pregnant women: making improved detection a good clinical outcome.
    Araojo R; McCune S; Feibus K
    Clin Pharmacol Ther; 2008 Apr; 83(4):520-2. PubMed ID: 18349872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis.
    Ostrea EM; Knapp DK; Tannenbaum L; Ostrea AR; Romero A; Salari V; Ager J
    J Pediatr; 2001 Mar; 138(3):344-8. PubMed ID: 11241040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of drug use during pregnancy.
    Kwong TC; Shearer D
    Obstet Gynecol Clin North Am; 1998 Mar; 25(1):43-64. PubMed ID: 9547759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.
    Wingert WE; Feldman MS; Kim MH; Noble L; Hand I; Yoon JJ
    J Forensic Sci; 1994 Jan; 39(1):150-8. PubMed ID: 8113697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health.
    Koren G; Hutson J; Gareri J
    Clin Pharmacol Ther; 2008 Apr; 83(4):631-4. PubMed ID: 18288086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of gestational cocaine exposure: sensitivity of infants' hair, meconium, and urine.
    Callahan CM; Grant TM; Phipps P; Clark G; Novack AH; Streissguth AP; Raisys VA
    J Pediatr; 1992 May; 120(5):763-8. PubMed ID: 1578314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Biological Screening and Diagnostic Indicators to Detect In Utero Opiate and Cocaine Exposure Among Mother-Infant Dyads.
    Stabler M; Giacobbi P; Chertok I; Long L; Cottrell L; Yossuck P
    Ther Drug Monit; 2017 Dec; 39(6):640-647. PubMed ID: 28937537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of cocaine usage in pregnant women by a urinary EMIT drug screen and GC-MS analyses.
    DiGregorio GJ; Ferko AP; Barbieri EJ; Ruch EK; Chawla H; Keohane D; Rosenstock R; Aldano A
    J Anal Toxicol; 1994 Sep; 18(5):247-50. PubMed ID: 7990440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews.
    Bibb KW; Stewart DL; Walker JR; Cook VD; Wagener RE
    J Perinatol; 1995; 15(3):199-202. PubMed ID: 7666268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug screening during pregnancy: Urine dip cups measure up.
    Kroska EB; Meller EW; Doyle R; Coker JL; Knight BT; Ray-Griffith SL; Nembhard WN; Stowe ZN
    Drug Alcohol Depend; 2019 Nov; 204():107461. PubMed ID: 31521952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [False positive screening for drugs of abuse].
    Watine J
    Ann Biol Clin (Paris); 2003; 61(3):367-8. PubMed ID: 12825552
    [No Abstract]   [Full Text] [Related]  

  • 13. A descriptive regional study of drug and alcohol use in pregnant women using results from urine drug testing by liquid chromatography-tandem mass spectrometry.
    Kreshak A; Villano J; Clark A; Deak P; Clark R; Miller C
    Am J Drug Alcohol Abuse; 2016 Mar; 42(2):178-86. PubMed ID: 26811262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the prevalence of drug misuse by meconium analysis.
    Williamson S; Jackson L; Skeoch C; Azzim G; Anderson R
    Arch Dis Child Fetal Neonatal Ed; 2006 Jul; 91(4):F291-2. PubMed ID: 16790733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing for exposure to illicit drugs and other agents in the neonate: a review of laboratory methods and the role of meconium analysis.
    Ostrea EM
    Curr Probl Pediatr; 1999 Feb; 29(2):37-56. PubMed ID: 10021686
    [No Abstract]   [Full Text] [Related]  

  • 16. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium.
    Montgomery D; Plate C; Alder SC; Jones M; Jones J; Christensen RD
    J Perinatol; 2006 Jan; 26(1):11-4. PubMed ID: 16281047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meconium drug screening to detect prenatal substance abuse.
    Wildman KM; Mohl V; Houston R; Allerheiligen D
    J Fam Pract; 1996 Nov; 43(5):501-2. PubMed ID: 8917151
    [No Abstract]   [Full Text] [Related]  

  • 18. In utero drugs of abuse exposure testing for newborn twins.
    Wang P; Molina CP; Maldonado JE; Bernard DW
    J Clin Pathol; 2010 Mar; 63(3):259-61. PubMed ID: 20203227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs of abuse testing in meconium.
    Gareri J; Klein J; Koren G
    Clin Chim Acta; 2006 Apr; 366(1-2):101-11. PubMed ID: 16413011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alternative biological materials to detect prenatal exposure to drugs of abuse in the third trimester of pregnancy].
    García-Serra J; Ramis J; Simó S; Joya X; Pichini S; Vall O; García-Algar O
    An Pediatr (Barc); 2012 Nov; 77(5):323-8. PubMed ID: 22513392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.